Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Targeted drugs for metastatic renal cell carcinoma.

× No keyword cloud information.

34 in total

1. Management of kidney cancer: canadian kidney cancer forum consensus update 2011.

Authors: Mas Jewett; A Finelli; C Kollmannsberger; L Wood; L Legere; J Basiuk; C Canil; D Heng; N Reaume; S Tanguay; M Atkins; G Bjarnason; J Dancey; M Evans; N Fleshner; M Haider; A Kapoor; R Uzzo; D Maskens; D Soulieres; G Yousef; N Basappa; N Bendali; P Black; N Blais; I Cagiannos; M Care; R Chow; H Chung; P Czaykowski; D Derosa; K Durrant; S Ellard; G Farquharson; C Filion-Brulotte; J Gingerich; L Godbout; R Grant; W Hamilton; W Kassouf; G Kurban; K Lane; Jb Lattouf; D Lau; M Leveridge; J McCarthy; R Moore; S North; P O'brien; E Pituskin; P Racine; R Rendon; A So; S Sridhar; K Stubbs; Z Su; L Taylor; T Udall; P Venner; W Vogel; S Yap; P Yau; M Cooper; N Giroux; D Miron; D Mosher; K Ross; J Willacy
Journal: Can Urol Assoc J Date: 2012-02 Impact factor: 1.862

2. Diagnostic accuracy and clinical impact of imaging-guided needle biopsy of renal masses. Retrospective analysis on 150 cases.

Authors: Andrea Veltri; Irene Garetto; Irene Tosetti; Marco Busso; Alessandro Volpe; Donatella Pacchioni; Enrico Bollito; Mauro Papotti
Journal: Eur Radiol Date: 2010-09-01 Impact factor: 5.315

Review 3. Sunitinib in metastatic renal cell carcinoma: recommendations for management of noncardiovascular toxicities.

Authors: Christian Kollmannsberger; Georg Bjarnason; Patrick Burnett; Patricia Creel; Mellar Davis; Nancy Dawson; Darren Feldman; Suzanne George; Jerome Hershman; Thomas Lechner; Amy Potter; Eric Raymond; Nathaniel Treister; Laura Wood; Shenhong Wu; Ronald Bukowski
Journal: Oncologist Date: 2011-04-13

4.

Authors:
Journal: Can Urol Assoc J Date: 2009-06 Impact factor: 1.862

5. A digest on the role of the tumor microenvironment in gastrointestinal cancers.

Authors: Martin Augsten; Christina Hägglöf; Cristina Peña; Arne Ostman
Journal: Cancer Microenviron Date: 2010-03-07

6. Anti-angiogenesis approach to genitourinary cancer treatment.

Authors: Jeanny B Aragon-Ching; William L Dahut
Journal: Update Cancer Ther Date: 2009

Review 7. Zoledronic acid in genitourinary cancer.

Authors: M A Climent; U Anido; M J Méndez-Vidal; J Puente
Journal: Clin Transl Oncol Date: 2013-04-25 Impact factor: 3.405

8. Phase I study combining treatment with temsirolimus and sunitinib malate in patients with advanced renal cell carcinoma.

Authors: Premal H Patel; Peggy L Senico; Rafael E Curiel; Robert J Motzer
Journal: Clin Genitourin Cancer Date: 2009-01 Impact factor: 2.872

9. Gene microarray analysis of human renal cell carcinoma: the effects of HDAC inhibition and retinoid treatment.

Authors: Trisha S Tavares; David Nanus; Ximing J Yang; Lorraine J Gudas
Journal: Cancer Biol Ther Date: 2008-10-09 Impact factor: 4.742

10. Phase I trial of metastatic renal cell carcinoma with oral capecitabine and thalidomide.

Authors: Anja Kraemer; Stefan Hauser; Young Kim; Marcus Gorschlüter; Stefan C Müller; Peter Brossart; Ingo G H Schmidt-Wolf
Journal: Ger Med Sci Date: 2009-06-10